Daewoong Co., Ltd. (KRX:003090)
South Korea
· Delayed Price · Currency is KRW 22,100
-1,500 (-6.36%)
Mar 9, 2026, 3:30 PM KST
Daewoong Revenue
Daewoong had revenue of 542.18B KRW in the quarter ending September 30, 2025, with 5.10% growth. This brings the company's revenue in the last twelve months to 2.06T, up 9.35% year-over-year. In the year 2024, Daewoong had annual revenue of 1.94T with 6.79% growth.
Revenue (ttm)
2,055.93B
Revenue Growth
+9.35%
P/S Ratio
0.44
Revenue / Employee
5.42B
Employees
379
Market Cap
903.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,936.92B | 123.08B | 6.79% |
| Dec 31, 2023 | 1,813.84B | 116.50B | 6.86% |
| Dec 31, 2022 | 1,697.34B | 185.96B | 12.30% |
| Dec 31, 2021 | 1,511.37B | 156.04B | 11.51% |
| Dec 31, 2020 | 1,355.34B | -10.34B | -0.76% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DongKook Pharmaceutical | 894.93B |
| Ildong Pharmaceutical | 575.66B |
| Boryung | 1,028.99B |
| Huons Global | 825.44B |
| Chong Kun Dang Pharmaceutical | 1,680.99B |
| JW Pharmaceutical | 764.21B |
| Dong-A Socio Holdings | 1,404.83B |
| Shinpoong Pharmaceutical Co.,Ltd | 231.90B |
Daewoong News
- 6 weeks ago - AEON Biopharma Completes BPD Type 2a Meeting With FDA - Nasdaq